摘要
IgG4-related disease (IgG4-RD) can involve the kidneys, causing IgG4-related kidney disease (IgG4-KRD). Diagnosis requires integration of clinical, serological, imaging, and pathological findings. Large-scale domestic data on renal involvement are limited. This retrospective study analyzed 6 biopsy-proven IgG4-KRD cases to summarize clinicopathological features and prognostic factors.
Six patients who underwent renal biopsy at the Second Hospital of Jilin University from 2018 to 2024 and met the 2020 diagnostic criteria for IgG4-KRD were retrospectively reviewed.
1. Clinical features Four males, two females; median age 64 years (range 50–75). Onset was insidious. Most common presenting symptom: renal dysfunction (4 cases with elevated creatinine), followed by proteinuria and submandibular gland enlargement. All had extrarenal involvement (lung, pancreas/biliary tract, retroperitoneal fibrosis). Two had allergic rhinitis, and one had multiple allergies. 2. Laboratory and imaging All had elevated serum IgG and/or IgG4 (5 with IgG >20 g/L). Hypocomplementemia (low C3/C4) in 4 cases; eosinophilia in 2. Baseline serum creatinine: 54–831 μmol/L; eGFR 5.2–109.2 ml/min, with 4 cases having eGFR <30 ml/min. Imaging showed enlarged kidneys, cysts, hydronephrosis, or retroperitoneal fibrosis. 3. Pathology Renal biopsies showed interstitial inflammatory infiltration and fibrosis with tubular atrophy. Diagnoses: acute/subacute/chronic tubulointerstitial nephritis (TIN) in 4 cases; TIN with ANCA-associated glomerulonephritis in 2. Key findings: tubular protein casts (100%), interstitial fibrosis (83.3%), inflammatory cell infiltration (100%), plasma cell infiltration (100%), eosinophils (66.7%), and small artery wall thickening (66.7%). All received glucocorticoids; 2 combined with cyclophosphamide, 1 with rituximab. After treatment, 5 had significant renal improvement. One patient (case 2) had end-stage renal disease at presentation (eGFR 5.2→4.4 ml/min, creatinine 831→947 μmol/L), indicating poor prognosis. Early treatment correlated with better renal recovery. ANCA positivity did not significantly affect outcomes.
IgG4-KRD presents with variable manifestations; renal dysfunction is often the first sign. Elevated serum IgG4, hypocomplementemia, and extrarenal involvement are important clues, but renal biopsy is required for diagnosis. Early adequate glucocorticoids plus immunosuppressants improve renal function. Delayed diagnosis, extensive fibrosis, and ESRD predict poor prognosis. ANCA-positive patients may also benefit from combination immunotherapy.
